| Company name | Group | Parent | Subsidiary | Customer | Supplier | Alliance | Bank | Shareholder |
|---|---|---|---|---|---|---|---|---|
| M3 Inc. | ||||||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
| Clinical Porter Co., Ltd. | ||||||||
| Medisaiensu Planning Co., Ltd. | ||||||||
| NEUES Co., Ltd. | ||||||||
| Nuvel Plus Co., Ltd. | ||||||||
| 米国PHT社 |
Establishment
Establishment of Medical Support Inc.
Changed company name to Mebix Corporation and relocated headquarters to Shibuya-ku, Tokyo: Started providing CapTool® services
Opened sales and development office in Chiyoda-ku, Tokyo
Relocated headquarters to Kanda Surugadai, Chiyoda-ku, Tokyo
Established a subsidiary, Clinical Porter Inc. (100% owned)
Opened Osaka Office in Chuo Ward, Osaka City
Obtained ISO9001:2000 Quality Management System Standard
Relocated headquarters to Kanda Ogawamachi in the same ward
Relocated Osaka Office to Imabashi, Chuo Ward, Osaka City
Business alliance with M3 Inc.
Listed on the Tokyo Stock Exchange Mothers Market
Received the Minister of Economy, Trade and Industry Award in the SME Agency's 'Japan Venture Award 2006' Entrepreneurial Division
Relocated headquarters to Koishikawa, Bunkyo Ward, Tokyo
Business alliance with PHT Inc. in the United States
Obtained patent for 'Clinical Trial Allocation System' (Patent No. 4109599)
Signed a business alliance agreement with M3 Inc. for joint support services for clinical and epidemiological research
As a result of M3 Inc.'s tender offer for our common stock, M3 Inc. became our top shareholder
Delisted from the Tokyo Stock Exchange Mothers Market following becoming a wholly owned subsidiary of M3 Inc.
Relocated headquarters to Daimon, Minato Ward, Tokyo
Started providing CapTool® Prime service
Obtained CDISC certification for CapTool® Prime, the first in Japan
Relocated headquarters to Akasaka, Minato Ward, Tokyo
Established Toranomon Office in Minato Ward, Tokyo
Established a dedicated clinical research operations room
Relocated Toranomon Office to new address
Established Clinical Research 2.0 Promotion Office
Mebix Inc. has published a page introducing its research support using electronic medical records (EMRs). It explains how seamless integration between EMRs and CapTool can address inefficiencies in traditional clinical research and promote reliable patient enrollment. The page also introduces a feature that displays pop-up notifications within the EMR.
Mebix Inc. published a page about research support using electronic medical records. It explains how seamless integration between electronic medical records and CapTool can address inefficiencies in traditional clinical research and enable prospective study designs. It also introduces pop-up notifications to promote reliable patient enrollment.
Mebix Inc. has published a page introducing its qualitative research support service for pharmaceutical companies, including qualitative interview studies. The service aims to turn patients’ voices into evidence. The page states that inquiries from academic institutions are not currently being accepted.
Mebix Inc. published an information page about its qualitative research support services, including qualitative interviews, for pharmaceutical companies. The services aim to turn patient perspectives into evidence. The page states that inquiries from academic institutions are not accepted.
Mebix Inc. held its 14th Medical Affairs Forum to promote clinical research. The forum invited clinical research professionals from pharmaceutical companies and medical device manufacturers.
Mebix Inc. held its 14th Medical Affairs Forum to promote clinical research, inviting clinical research professionals from pharmaceutical and medical device companies.
On January 23, 2023, Mebix Inc. launched the Patient Outcome Team, focused on physician and patient survey research. The new team provides specialized support for such research and strengthens the company's clinical research operations.
Mebix Inc. established the Patient Outcome Team, specializing in physician and patient survey research. The company began such research in 2021 and now provides research support through the dedicated team.
Mebix Inc. announced a free webinar to promote clinical research. The seventh session will focus on “Patient Questionnaire Research: From Predisease to Treatment.”
The 12th Medical Affairs Forum was held, bringing together clinical research professionals from pharmaceutical companies and medical device manufacturers to promote clinical research. The forum provided a venue for participants to exchange information and build collaborative relationships.